Resolvin E1 receptor activation signals phosphorylation and phagocytosis

Journal of Biological Chemistry

Volumn 285, Issue 5, 2010, Pages 3451-3461

  Ohira, Taisuke ^a,b   Arita, Makoto ^a,c   Omori, Kazuhiro ^b   Recchiuti, Antonio ^a   Van Dykeand, Thomas E ^b   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AKT PHOSPHORYLATION; ANTI-INFLAMMATORIES; APOPTOTIC; CHINESE HAMSTER OVARY CELLS; DIRECT ACTIVATION; DOSE-DEPENDENT; DOWNSTREAM TARGET; EICOSAPENTAENOIC ACID; G PROTEIN COUPLED RECEPTORS; HL-60 CELLS; HUMAN MACROPHAGES; LEUKOCYTE MIGRATION; LIPID MEDIATORS; PHOSPHATIDYLINOSITOL 3-KINASE; RAPAMYCIN; RECEPTOR ACTIVATION; RECEPTOR-LIGAND INTERACTIONS; REGULATORY ACTIONS; RIBOSOMAL PROTEINS; SIGNALING PATHWAYS; WORTMANNIN;

ACIDS; ANTIGEN-ANTIBODY REACTIONS; LAWS AND LEGISLATION; LIGANDS; MACROPHAGES; PATHOLOGY; PIGMENTS; PROTEINS; SIGNALING;

PHOSPHORYLATION;

ANTIINFLAMMATORY AGENT; PROTEIN KINASE B; PROTEIN S6; RESOLVIN E1 RECEPTOR; UNCLASSIFIED DRUG; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 5S,12R,18R TRIHYDROXY 6Z,8E,10E,14Z,16E EICOSAPENTAENOIC ACID; 5S,12R,18R-TRIHYDROXY-6Z,8E,10E,14Z,16E-EICOSAPENTAENOIC ACID; CHEMOKINE RECEPTOR; CMKLR1 PROTEIN, HUMAN; DRUG DERIVATIVE; FLAVONOID; ICOSAPENTAENOIC ACID; LIPID; RAPAMYCIN; ZYMOSAN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MACROPHAGE; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CELL STRAIN HL 60; CHEMISTRY; CHO CELL; CRICETULUS; HAMSTER; INFLAMMATION; METABOLISM; PHOSPHORYLATION;

CRICETULUS GRISEUS;

ANIMALS; CELL DIFFERENTIATION; CHO CELLS; CRICETINAE; CRICETULUS; EICOSAPENTAENOIC ACID; FLAVONOIDS; HL-60 CELLS; HUMANS; INFLAMMATION; LIPIDS; MACROPHAGES; PHAGOCYTOSIS; PHOSPHORYLATION; RECEPTORS, CHEMOKINE; SIROLIMUS; ZYMOSAN;

EID: 77449097856     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M109.044131     Document Type: Article

References (31)

1. Serhan, C. N., and Savill, J. (2005) Nat. Immunol. 6, 1191-1197
2. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Nat. Rev. Drug. Discov. 3, 401-416
3. Shimizu, T. (2009) Annu. Rev. Pharmacol. Toxicol. 49, 123-150
4. Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A., Perretti, M., Rossi, A. G., and Wallace, J. L. (2007) FASEB J. 21, 325-332
5. Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000) J. Exp. Med. 192, 1197-1204
6. Gronert, K. (2008) Mol. Interv. 8, 28-35
7. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., and Moussignac, R. L. (2002) J. Exp. Med. 196, 1025-1037
8. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., and Serhan, C. N. (2005) J. Exp. Med. 201, 713-722
9. Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N. A., Levy, B. D., Serhan, C. N., and Van Dyke, T. E. (2006) FASEB J. 20, 401-403
10. Hong, S., Porter, T. F., Lu, Y., Oh, S. F., Pillai, P. S., and Serhan, C. N. (2008) J. Immunol. 180, 3512-3519
11. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., and Serhan, C. N. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 7671-7676
12. Serhan, C. N. (2007) Annu. Rev. Immunol. 25, 101-137
13. Schwab, J. M., Chiang, N., Arita, M., and Serhan, C. N. (2007) Nature 447, 869-874
14. Connor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D., Hellstrom, A., Kang, J. X., Chew, E. Y., Salem, N., Jr., Serhan, C. N., and Smith, L. E. (2007) Nat. Med. 13, 868-873
15. Arita, M., Ohira, T., Sun, Y. P., Elangovan, S., Chiang, N., and Serhan, C. N. (2007) J. Immunol. 178, 3912-3917
16. Cash, J. L., Hart, R., Russ, A., Dixon, J. P., Colledge, W. H., Doran, J., Hendrick, A. G., Carlton, M. B., and Greaves, D. R. (2008) J. Exp. Med. 205, 767-775
17. Campbell, E. L., Louis, N. A., Tomassetti, S. E., Canny, G. O., Arita, M., Serhan, C. N., and Colgan, S. P. (2007) FASEB J. 21, 3162-3170
18. Böyum, A. (1968) Scand. J. Clin. Lab. Invest. Suppl. 21, 77-89
19. Ohira, T., Zhan, Q., Ge, T., Van Dyke, T., and Badwey, J. A. (2003) J. Immunol. Methods 281, 79-94
20. Zabel, B. A., Zuniga, L., Ohyama, T., Allen, S. J., Cichy, J., Handel, T. M., and Butcher, E. C. (2006) Exp. Hematol. 34, 1021-1032
21. Alessi, D. R., Caudwell, F. B., Andjelkovic, M., Hemmings, B. A., and Cohen, P. (1996) FEBS Lett. 399, 333-338
22. Ly, C., Arechiga, A. F., Melo, J. V., Walsh, C. M., and Ong, S. T. (2003) Cancer Res. 63, 5716-5722
23. Yoshimura, T., and Oppenheim, J. J. (2008) J. Exp. Med. 205, 2187-2190
24. Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., and Levy, B. D. (2008) Nat. Immunol. 9, 873-879
25. Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Kawata, T., Shimizu, Y., Okajima, F., Dobashi, K., and Mori, M. (2008) Biochem. Biophys. Res. Commun. 367, 509-515
26. Ganesan, L. P., Wei, G., Pengal, R. A., Moldovan, L., Moldovan, N., Ostrowski, M. C., and Tridandapani, S. (2004) J. Biol. Chem. 279, 54416-54425
27. Maderna, P., and Godson, C. (2003) Biochim. Biophys. Acta 1639, 141-151
28. Vassiliou, E. K., Kesler, O. M., Tadros, J. H., and Ganea, D. (2008) J. Immunol. 181, 4534-4544
29. Maudsley, S., Martin, B., and Luttrell, L. M. (2005) J. Pharmacol. Exp. Ther. 314, 485-494
30. Savinainen, A., Qin, S., Crandall, T., Dubrovskiy, A., Trocha, M., Schwartz, E., Gjorstrup, P., and Wu, L. (2007) 10th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, Montreal, September 16-19, 2007 (abstract)
31. Starosta, V., Pazdrak, K., Boldogh, I., Svider, T., and Kurosky, A. (2008) J. Immunol. 181, 8688-8699